Mercer Global Advisors
PBLS

Mercer Global Advisors’s Parabilis Medicines Inc PBLS Stock Holding History

Mercer Global Advisors’s Portfolio PBLS Stock Details PBLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67K Buy
+61
New +$1.69K ﹤0.01% 5631

Other funds holding PBLS

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return

Mercer Global Advisors's PBLS Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Parabilis Medicines Inc (PBLS) in Q2 2026: 61 shares worth $1.67K. The stake represents ﹤0.01% of the portfolio and ranks #5631 among its holdings.

37 funds tracked by Wall St. Rank hold PBLS as of Q2 2026.

  • Mercer Global Advisors held 61 shares of Parabilis Medicines Inc worth $1.67K as of Q2 2026.
  • Parabilis Medicines Inc was a new Mercer Global Advisors position in Q2 2026.
  • Parabilis Medicines Inc made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5631 holding.
  • 37 funds tracked by Wall St. Rank held Parabilis Medicines Inc as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.